Bicara Therapeutics Inc. (BCAX)

Latest Insider Confidence Score

2026Q1

51.0
Bullish

Company insider confidence (by quarter)

2024Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Tpg Gp A, Llc — 1,960,425 Sep 18, 2024
Coulter James G — 1,960,425 Sep 18, 2024
Winkelried Jon — 1,960,425 Sep 18, 2024
Bonderman David — 1,960,425 Sep 18, 2024
Ra Capital Management, L.P. Director 1,172,334 Sep 18, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 4, 2026 Mar 6, 2026 Mazumdar Claire CEO Sell 48.8 -8,234 -0.80% ✓ $154.3K
Mar 3, 2026 Mar 5, 2026 Cohlhepp Ryan COO Sell 28.8 -17,392 -7.82% ✓ $315.9K
Mar 3, 2026 Mar 5, 2026 Hyep Ivan CFO Sell 32.5 -16,518 -5.38% ✓ $301K
Mar 3, 2026 Mar 5, 2026 Raben David Chief Medical Officer Sell 25.0 -16,500 -12.98% ✓ $305.6K
Feb 26, 2026 Mar 2, 2026 RA CAPITAL MANAGEMENT, L.P. Director Buy 95.0 +300,000 6.97% ✗ $4.8M
Feb 25, 2026 Feb 27, 2026 Cohlhepp Ryan COO Sell 46.3 -3,631 -1.70% ✓ $65.5K
Feb 2, 2026 Feb 4, 2026 Cohlhepp Ryan COO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Mazumdar Claire CEO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Raben David Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Hyep Ivan CFO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Meisner Lara Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Jan 22, 2026 Jan 26, 2026 Cohlhepp Ryan COO Sell 46.3 -3,828 -1.79% ✓ $69.3K
Jan 22, 2026 Jan 26, 2026 Hyep Ivan CFO Sell 48.1 -1,882 -1.28% ✓ $34.2K
Jan 15, 2026 Jan 20, 2026 Cohlhepp Ryan COO Sell 55.0 -149 -0.07% ✓ $2.7K
Dec 26, 2025 Dec 29, 2025 Cohlhepp Ryan COO Neutral 52.5 - 0.00% ✗ -
Dec 26, 2025 Dec 29, 2025 Raben David Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 22, 2025 Dec 23, 2025 Hyep Ivan CFO Sell 33.8 -9,200 -5.95% ✓ $168.5K
Dec 16, 2025 Dec 18, 2025 Mazumdar Claire CEO Neutral 52.5 - 0.00% ✗ -
Dec 15, 2025 Dec 16, 2025 Cohlhepp Ryan COO Sell 32.5 -12,500 -6.20% ✓ $233.5K
Nov 21, 2025 Nov 25, 2025 Hyep Ivan CFO Sell 30.0 -18,400 -5.95% ✓ $341.1K
Nov 21, 2025 Nov 25, 2025 Cohlhepp Ryan COO Sell 32.5 -12,500 -6.06% ✓ $225.6K
Nov 24, 2025 Nov 25, 2025 Mazumdar Claire CEO Sell 22.5 -41,163 -11.73% ✓ $776.4K
Nov 24, 2025 Nov 25, 2025 Raben David Chief Medical Officer Sell 28.8 -11,000 -9.36% ✓ $205.1K
Oct 15, 2025 Oct 16, 2025 Cohlhepp Ryan COO Sell 32.5 -12,500 -5.93% ✓ $226.9K
Oct 13, 2025 Oct 15, 2025 Mazumdar Claire CEO Sell 35.0 -24,734 -3.84% ✓ $466.9K
Oct 9, 2025 Oct 10, 2025 Raben David Chief Medical Officer Sell 7.5 -22,000 -38.26% ✓ $405.9K
Oct 9, 2025 Oct 10, 2025 Hyep Ivan CFO Sell 37.5 -6,415 -4.23% ✓ $116.9K
Oct 6, 2025 Oct 8, 2025 Hyep Ivan CFO Sell 30.0 -30,385 -6.51% ✓ $553.2K
Oct 6, 2025 Oct 8, 2025 Cohlhepp Ryan COO Sell 30.0 -50,500 -5.70% ✓ $911.8K
Sep 29, 2025 Oct 1, 2025 Meisner Lara Chief Legal Officer Sell 7.5 -33,807 -100.00% ✓ $498.7K
Sep 15, 2025 Sep 17, 2025 Meisner Lara Chief Legal Officer Sell 10.0 -15,829 -100.00% ✓ $181.9K
Jun 16, 2025 Jun 18, 2025 Meisner Lara Chief Legal Officer Sell 10.0 -15,829 -100.00% ✓ $165.1K
Jun 9, 2025 Jun 10, 2025 Haviland Kate Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2025 Jun 10, 2025 RA CAPITAL MANAGEMENT, L.P. Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2025 Jun 10, 2025 Mazumdar-Shaw Kiran Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2025 Jun 10, 2025 POWELL MICHAEL Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2025 Jun 10, 2025 LONBERG NILS Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2025 Jun 10, 2025 Robertson Scott M. Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2025 Jun 10, 2025 Simson Jake Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2025 Jun 10, 2025 Bowden Christopher Director Neutral 52.5 - 0.00% ✗ -
Mar 14, 2025 Mar 18, 2025 Meisner Lara Chief Legal Officer Sell 5.0 -79,146 -100.00% ✓ $1M
Sep 16, 2024 Sep 18, 2024 RA CAPITAL MANAGEMENT, L.P. Director Buy 100.0 +1,833,000 35.78% ✗ $33M
Sep 16, 2024 Sep 18, 2024 TPG GP A, LLC Other Neutral 52.5 - 0.00% ✗ -
Sep 16, 2024 Sep 18, 2024 FIL Ltd Other Neutral 52.5 - 0.00% ✗ -
Sep 16, 2024 Sep 18, 2024 FMR LLC Other Neutral 52.5 - 0.00% ✗ -
Sep 17, 2024 Sep 17, 2024 Flynn James E 10% Owner Buy 92.5 +70,000 4.06% ✗ $1.3M
Sep 12, 2024 Sep 16, 2024 RA CAPITAL MANAGEMENT, L.P. Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Sep 16, 2024 LONBERG NILS Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Sep 16, 2024 Simson Jake Director Neutral 52.5 - 0.00% ✗ -
Sep 16, 2024 Sep 16, 2024 Biocon Ltd 10% Owner Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Sep 16, 2024 Haviland Kate Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Sep 16, 2024 Robertson Scott M. Director Neutral 52.5 - 0.00% ✗ -
Sep 16, 2024 Sep 16, 2024 Mazumdar-Shaw Kiran Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 RA CAPITAL MANAGEMENT, L.P. Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Simson Jake Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Meisner Lara Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Hyep Ivan CFO Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 POWELL MICHAEL Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Raben David Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Mazumdar-Shaw Kiran Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Bowden Christopher Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Mazumdar Claire CEO Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Cohlhepp Ryan COO Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Flynn James E 10% Owner Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 LONBERG NILS Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 NG CAROLYN Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Biocon Ltd 10% Owner Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Robertson Scott M. Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 Haviland Kate Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 FMR LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 FIL Ltd 10% Owner Neutral 52.5 - 0.00% ✗ -
Sep 12, 2024 TPG GP A, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -